3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
34
NIH
10
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Fallopian Tube Neoplasms
2
Uterine Cervical Neoplasms
1
Turcot syndrome
1
Stomach Neoplasms
1
Ovarian Neoplasms
1
Oesophagogastric Cancer
1
Neoplasms, Squamous Cell
1
Lung Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Ovarian Epithelial
1
Breast Neoplasms
1
Interventions
Irinotecan
11
Oxaliplatin
8
Cetuximab
7
Fluorouracil
6
Leucovorin
5
Bevacizumab
5
Standard of Care
4
S 1 (combination)
4
Capecitabine
4
trifluridine tipiracil drug combination
2
tislelizumab
2
apatinib
2
Propranolol
2
Preoperative Exercise
2
Panitumumab
2
Levoleucovorin
2
Folfox protocol
2
Etodolac
2
Endoscopic Mucosal Resection
2
Drug Therapy
2
Chemotherapy, Adjuvant
2
trebananib
1
regorafenib
1
envafolimab
1
Trifluridine
1
Thalidomide
1
Surveys and Questionnaires
1
Occult Blood
1
Neoadjuvant Therapy
1
Moxibustion
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Colorectal Neoplasms
×
Neoadjuvant Therapy
×
Clear all
NCT05913570
2023-06-22
MSI-H/dMMR
Henan Cancer Hospital
Phase 2
Unknown
22 enrolled